Literature DB >> 30968811

Left rostrolateral prefrontal cortex lesions reduce suicidal ideation in penetrating traumatic brain injury.

Matteo Pardini1, Jordan Grafman2, Vanessa Raymont3,4, Mario Amore1, Gianluca Serafini1, Michael Koenigs5, Frank Krueger6.   

Abstract

OBJECTIVES: The objective of this study is to evaluate the relationship between suicidal ideation (SI), structural brain damage, and cognitive deficits in patients with penetrating traumatic brain injury (pTBI).
METHODS: Vietnam War veterans (n = 142) with pTBI to the prefrontal cortex (PFC) underwent combination of neuropsychological and psychiatric examinations and non-contrast CT brain scan. Patients were divided into SI positive (SI+) and SI negative (SI-) groups according to the SI item of the Beck Depression Inventory.
RESULTS: Lesions to the left rostrolateral PFC (rlPFC) were associated with a lower risk of SI independent of depression and global functioning. Left rlPFC lesion also reduced abstract reasoning skills, which mediated the lesion effects on suicide ideation.
CONCLUSIONS: The left rlPFC plays a crucial role in SI independently of depression and global functioning.

Entities:  

Keywords:  Suicidality; cognition; frontal lobe; traumatic brain injury

Mesh:

Year:  2020        PMID: 30968811      PMCID: PMC6786933          DOI: 10.1017/S1092852918001694

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  41 in total

1.  User-friendly software for the analysis of brain lesions (ABLe).

Authors:  Jeffrey Solomon; Vanessa Raymont; Allen Braun; John A Butman; Jordan Grafman
Journal:  Comput Methods Programs Biomed       Date:  2007-04-03       Impact factor: 5.428

2.  Improving lesion-symptom mapping.

Authors:  Chris Rorden; Hans-Otto Karnath; Leonardo Bonilha
Journal:  J Cogn Neurosci       Date:  2007-07       Impact factor: 3.225

Review 3.  Prefrontal cortical regulation of hypothalamic-pituitary-adrenal function in the rat and implications for psychopathology: side matters.

Authors:  Ron M Sullivan; Alain Gratton
Journal:  Psychoneuroendocrinology       Date:  2002 Jan-Feb       Impact factor: 4.905

4.  The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.

Authors:  Kelly Posner; Gregory K Brown; Barbara Stanley; David A Brent; Kseniya V Yershova; Maria A Oquendo; Glenn W Currier; Glenn A Melvin; Laurence Greenhill; Sa Shen; J John Mann
Journal:  Am J Psychiatry       Date:  2011-12       Impact factor: 18.112

5.  Suicidal ideation is associated with reduced prefrontal activation during a verbal fluency task in patients with major depressive disorder.

Authors:  Shenghong Pu; Kazuyuki Nakagome; Takeshi Yamada; Katsutoshi Yokoyama; Hiroshi Matsumura; Sayaka Yamada; Takuya Sugie; Akihiko Miura; Hideaki Mitani; Masaaki Iwata; Izumi Nagata; Koichi Kaneko
Journal:  J Affect Disord       Date:  2015-04-11       Impact factor: 4.839

6.  Suicidality after traumatic brain injury: demographic, injury and clinical correlates.

Authors:  Grahame Simpson; Robyn Tate
Journal:  Psychol Med       Date:  2002-05       Impact factor: 7.723

7.  A neuropsychological investigation of the Delis-Kaplan Executive Function System.

Authors:  Ekaterina Keifer; Daniel Tranel
Journal:  J Clin Exp Neuropsychol       Date:  2013-11-18       Impact factor: 2.475

8.  Left frontal lobe contributions to concept formation: a quantitative MRI study of performance on the Delis-Kaplan Executive Function System Sorting Test.

Authors:  Eric M Fine; Dean C Delis; David Dean; Victoria Beckman; Bruce L Miller; Howard J Rosen; Joel H Kramer
Journal:  J Clin Exp Neuropsychol       Date:  2008-11-24       Impact factor: 2.475

9.  Global assessment of functioning. A modified scale.

Authors:  R C Hall
Journal:  Psychosomatics       Date:  1995 May-Jun       Impact factor: 2.386

10.  Human Lesion Studies in the 21st Century.

Authors:  Ralph Adolphs
Journal:  Neuron       Date:  2016-06-15       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.